Press Release

Global Dermatology Drugs Market Size and Share By Industry Demand, Worldwide Research, Prominent Players, Emerging Trends, Investment Opportunities and Revenue Expectation till 2027

The global “dermatology drugs market” size is expected to USD 63.99 billion by 2027, exhibiting a CAGR of 12.9% during the forecast period. The increasing prevalence of numerous skin diseases and disorders among the population is expected to spur opportunities for the market, states Fortune Business Insights, in a report, titled “Dermatology Drugs Market Size, Share & Industry Analysis, By Application (Acne, Psoriasis, Atopic Dermatitis, and Others), By Route of Administration (Oral, Parenteral, and Topical) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size stood at USD 36.82 billion in 2019.

The occurrence of coronavirus has exerted massive economic stress on sectors in various countries. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.

Get Request a Sample Copy of the Dermatology Drugs Report:

https://www.fortunebusinessinsights.com/enquiry/sample/dermatology-drugs-market-104432

Major Dermatology Drugs Market Key players covered in the report include:

  • Allergan (Dublin, Ireland)
  • Botanix Dermatology Drugs (NorthBridge, Australia)
  • Pfizer Inc. (New York, U.S)
  • Galderma S.A (Lausanne, Switzerland)
  • Bausch Health Companies Inc. (Bridgewater, U.S)
  • Novartis (Switzerland, Europe)
  • GlaxoSmithKline Plc. (London, U.K)
  • Valeant Dermatology Drugs International Inc. (New Jersey, U.S)
  • Johnson & Johnson (New Jersey, U.S)
  • Other Players

Dermatology Drugs Market Analysis 2021:

Market Driver:

Surging Patient Population to Back Growth

The growing number of patients suffering from acne, vitiligo, and dermatitis are expected to spur opportunities for market growth. According to the American Association of Dermatology in 2018, around 50 million people in the U.S had acne. The growing demand for effective products to cure skin infections and disorders coupled with high awareness among the young population will contribute positively to the growth of the market. According to Australian research, more than 4% of the population are affected by acne vulgaris in long term. The growing inclination towards skin health and care among millennials can have an excellent impact on the market growth in the forthcoming years. The increasing R&D investments by major companies owing to heavy demand for therapeutically effectual and cost-effective drugs will encourage the healthy growth of the market in the foreseeable future.

Diminished Demand for Dermatology Drugs to Impede Market amid COVID-19

The COVID-19 pandemic has critically impacted the global market because of the weakened demand for dermatology drugs. Pharmaceutical companies producing skin-related drugs experienced massive losses owing to the lockdown imposed by governments. Thus, leading to disrupted supply and demand. Social distance regulations coupled with lower demand for mandatory prescribed dermatology medications will further restrict the growth of the market. According to the American Association of Dermatology, the dermatologists in the U.S reported an approximately 43% decline in patient consultations during the pandemic crisis. In addition, declining production and demand will simultaneously affect market sales during the coronavirus pandemic.

For more information visit : 

https://www.fortunebusinessinsights.com/dermatology-drugs-market-104432

Regional Analysis:

Presence of Prominent Companies to Boost Market in North America

The market size in North America stood at USD 18.08 billion in 2019 and is expected to grow rapidly during the forecast period. The growth in the region is attributed to the increasing prevalence of dermatology infections. The presence of major players coupled with the introduction of novel products will further aid expansion in the region. Europe is expected to grow excellently during the forecast period owing to the heavy R&D investments for the development of effective drugs. The increasing sales of dermatology products are expected to enable speedy expansion of the market in the forthcoming years. Asia Pacific is expected to account for a high share during the forecast period owing to the growing awareness about the care & management of acne among the population. Latin America and Middle East & Africa are expected to experience a slow growth rate owing to the lower adoption of topical solutions coupled with a lack of awareness about medicines and therapies related to acne, dermatitis, and other skin conditions.

Key Development:

September 2020: Eli Lilly announced the introduction of an inspiring digital health solution for atopic dermatitis patient care & management.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermatology-drugs-market-104432

Table of Content:

1 Dermatology Drugs Market Overview

1.1 Dermatology Drugs Product Overview

1.2 Dermatology Drugs Market Segment by Type

1.3 Global Dermatology Drugs Market Size by Type (2015-2027)

1.3.1 Global Dermatology Drugs Market Size Overview by Type (2015-2027)

1.3.2 Global Dermatology Drugs Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Dermatology Drugs Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Dermatology Drugs Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Dermatology Drugs Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Dermatology Drugs Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Dermatology Drugs Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Dermatology Drugs Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Dermatology Drugs Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Dermatology Drugs Sales Breakdown by Type (2015-2027)

1.4.2 Europe Dermatology Drugs Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Dermatology Drugs Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Dermatology Drugs Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Dermatology Drugs Sales Breakdown by Type (2015-2027)

2 Global Dermatology Drugs Market Competition by Company

2.1 Global Top Players by Dermatology Drugs Sales (2015-2021)

2.2 Global Top Players by Dermatology Drugs Revenue (2015-2021)

2.3 Global Top Players Dermatology Drugs Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Dermatology Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Dermatology Drugs Market Competitive Situation and Trends

2.5.1 Dermatology Drugs Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Dermatology Drugs Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drugs as of 2019)

2.7 Date of Key Company Enter into Dermatology Drugs Market

2.8 Key Company Dermatology Drugs Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Dermatology Drugs Status and Outlook by Region (2015-2027)

3.1 Global Dermatology Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Dermatology Drugs Market Size Market Share by Region (2015-2021)

3.2.1 Global Dermatology Drugs Sales Market Share by Region (2015-2021)

3.2.2 Global Dermatology Drugs Revenue Market Share by Region (2015-2021)

3.2.3 Global Dermatology Drugs Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Dermatology Drugs Market Size Market Share by Region (2021-2027)

3.3.1 Global Dermatology Drugs Sales Market Share by Region (2021-2027)

3.3.2 Global Dermatology Drugs Revenue Market Share by Region (2021-2027)

3.3.3 Global Dermatology Drugs Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Dermatology Drugs Market Size By Growth (2015-2027)

3.4.1 North America Dermatology Drugs Revenue By Growth (2015-2027)

3.4.2 North America Dermatology Drugs Sales By Growth (2015-2027)

3.5 Asia-Pacific Dermatology Drugs Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Dermatology Drugs Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Dermatology Drugs Sales By Growth (2015-2027)

3.6 Europe Dermatology Drugs Market Size By Growth (2015-2027)

3.6.1 Europe Dermatology Drugs Revenue By Growth (2015-2027)

3.6.2 Europe Dermatology Drugs Sales By Growth (2015-2027)

3.7 Latin America Dermatology Drugs Market Size By Growth (2015-2027)

3.7.1 Latin America Dermatology Drugs Revenue By Growth (2015-2027)

3.7.2 Latin America Dermatology Drugs Sales By Growth (2015-2027)

3.8 Middle East and Africa Dermatology Drugs Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Dermatology Drugs Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Dermatology Drugs Sales By Growth (2015-2027)

4 Global Dermatology Drugs by Application

4.1 Dermatology Drugs Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Dermatology Drugs Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Dermatology Drugs Historic Sales by Application (2015-2021)

4.4 Global Dermatology Drugs Forecasted Sales by Application (2021-2027)

4.5 Key Regions Dermatology Drugs Market Size by Application

4.5.1 North America Dermatology Drugs by Application

4.5.2 Europe Dermatology Drugs by Application

4.5.3 Asia-Pacific Dermatology Drugs by Application

4.5.4 Latin America Dermatology Drugs by Application

4.5.5 Middle East and Africa Dermatology Drugs by Application

5 North America Dermatology Drugs Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Dermatology Drugs Sales Market Share by Country (2015-2021)

5.1.2 North America Dermatology Drugs Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Dermatology Drugs Sales Market Share by Country (2021-2027)

5.2.2 North America Dermatology Drugs Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Dermatology Drugs Market Size By Growth (2015-2027)

5.3.2 Canada Dermatology Drugs Market Size By Growth (2015-2027)

6 Europe Dermatology Drugs Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Dermatology Drugs Sales Market Share by Country (2015-2021)

6.1.2 Europe Dermatology Drugs Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Dermatology Drugs Sales Market Share by Country (2021-2027)

6.2.2 Europe Dermatology Drugs Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Dermatology Drugs Market Size By Growth (2015-2027)

6.3.2 France Dermatology Drugs Market Size By Growth (2015-2027)

6.3.3 U.K. Dermatology Drugs Market Size By Growth (2015-2027)

6.3.4 Italy Dermatology Drugs Market Size By Growth (2015-2027)

6.3.5 Russia Dermatology Drugs Market Size By Growth (2015-2027)

7 Asia-Pacific Dermatology Drugs Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Dermatology Drugs Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Dermatology Drugs Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Dermatology Drugs Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Dermatology Drugs Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Dermatology Drugs Market Size By Growth (2015-2027)

7.3.2 Japan Dermatology Drugs Market Size By Growth (2015-2027)

7.3.3 South Korea Dermatology Drugs Market Size By Growth (2015-2027)

7.3.4 India Dermatology Drugs Market Size By Growth (2015-2027)

7.3.5 Australia Dermatology Drugs Market Size By Growth (2015-2027)

7.3.6 Taiwan Dermatology Drugs Market Size By Growth (2015-2027)

7.3.7 Indonesia Dermatology Drugs Market Size By Growth (2015-2027)

7.3.8 Thailand Dermatology Drugs Market Size By Growth (2015-2027)

7.3.9 Malaysia Dermatology Drugs Market Size By Growth (2015-2027)

7.3.10 Philippines Dermatology Drugs Market Size By Growth (2015-2027)

Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Radiosurgery Market

Radiosurgery Market Size

Radiosurgery Market Share

Radiosurgery Market Trends

Radiosurgery Market Growth

Radiosurgery Market Analysis

Radiosurgery Market Business Opportunities

Radiosurgery Market Key Players

Radiosurgery Market Demand

Radiosurgery Market Competitive Landscape

Radiosurgery Market Segments

Radiosurgery Market Overview

Radiosurgery Industry

Radiosurgery Market Stastistic

Radiosurgery Market Devlopment Strategy

Radiosurgery Market Future Growth

Radiosurgery Market Research Methodology

Radiosurgery Market Drivers

Radiosurgery Market Manufacturers

Radiosurgery Market Revenue

Radiosurgery Market Growth Analysis

Radiosurgery Market Search Analysis

Radiosurgery Market Condition

Radiosurgery Market Covid Effect

Radiosurgery Market CAGR Value

Radiosurgery Market Updates

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close